Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
27. November 2025
3 min to read

Bifascicular Block Associated With Myocardial Infarction: A Marker of Proximal Left Anterior Descending Artery Occlusion Confirmed by the Artificial Intelligence-Based Smartphone App Queen of Hearts

Overview

This single-patient case report describes an elderly man presenting with chest pain, hypotension, and bifascicular block (BFB)—a combination of right bundle branch block (RBBB) and left anterior fascicular block (LAFB)—whose ECG showed QRS‑concordant anterior and lateral ST‑segment elevation consistent with a STEMI‑equivalent / occlusive myocardial infarction (OMI) pattern. Urgent coronary angiography revealed a long, severely calcified, near‑occlusive proximal left anterior descending (LAD) artery lesion, successfully treated with primary PCI and drug‑eluting stent implantation, achieving TIMI 3 flow. The Queen of Hearts (PMcardio) AI‑based smartphone app correctly classified the ECG as STEMI‑equivalent, identified atrial flutter and BFB, and predicted reduced left ventricular ejection fraction, later confirmed by echocardiography (EF 38%). This case highlights BFB with concordant anterior ST elevation as a high-risk marker of proximal LAD culprit OMI and provides anecdotal evidence that specialized AI-enabled ECG interpretation can support rapid and accurate decision-making in ACS. 

Published in: Cureus
Published on: 26 November 2025

Background

Accurate recognition of occlusive myocardial infarction in the presence of conduction disturbances remains challenging. While current ESC guidelines acknowledge bundle branch blocks as important in ACS, they do not specifically define bifascicular block (RBBB + LAFB) as a STEMI‑equivalent, despite its association with proximal LAD or left main occlusion, extensive myocardial injury, heart failure, and increased mortality. In parallel, AI-powered ECG tools, such as Queen of Hearts, aim to go beyond simple ST-elevation thresholds to detect STEMI-equivalent/OMI patterns and estimate ventricular function, potentially reducing both missed OMI cases and unnecessary cath-lab activations.

Methods

This single‑case report describes a 77‑year‑old man with multiple cardiovascular comorbidities evaluated by emergency medical services for prolonged chest pain. Serial 12-lead ECGs were obtained and interpreted by clinicians, and then processed using the Queen of Hearts (PMcardio) smartphone app, which analyzed rhythm, conduction, ST-T patterns, and predicted left ventricular ejection fraction. The patient underwent emergent coronary angiography and primary PCI of the culprit lesion. The diagnostic work-up included laboratory testing (cardiac biomarkers, renal function, and lipid profile) and transthoracic echocardiography on the day after PCI to quantify wall-motion abnormalities and systolic function, followed by guideline-directed medical therapy and short-term clinical follow-up.

Results

The initial ECG (page 2) showed atrial flutter with 4:1 AV conduction, complete RBBB, LAFB, and QRS‑concordant ST‑segment elevation in V1–V4 with additional lateral ST elevation (I, aVL, V6) and reciprocal inferior changes, leading to a working diagnosis of anterolateral STEMI in the context of new or presumably new BFB. A second ECG (page 3) demonstrated further progression of anterior ST elevation. The Queen of Hearts app labeled the tracing as STEMI‑equivalent, detected the bifascicular block and atrial flutter, and predicted an EF <40%. Coronary angiography (page 4 and Video 1) revealed a severely calcified, near‑occlusive proximal LAD stenosis, treated successfully with drug‑eluting stent implantation and restoration of TIMI 3 flow; other coronary vessels showed only mild, non‑obstructive disease. Post‑PCI ECG (page 5) showed persistence of BFB but resolution of ST elevation with QRS‑discordant T‑wave changes typical for RBBB. Laboratory testing demonstrated markedly elevated high‑sensitivity troponin I and NT‑proBNP with moderate anemia and chronic kidney disease (Table 1, page 6). Echocardiography (Video 2) confirmed apical akinesia, anterior/anteroseptal hypokinesia, EF 38%, biatrial enlargement, and moderate ischemic mitral regurgitation, consistent with the AI‑predicted LV dysfunction. The in-hospital course was uncomplicated, and the patient was discharged after eight days on optimized heart failure and antithrombotic therapy.

Conclusion

In the appropriate clinical context, bifascicular block (RBBB + LAFB) with QRS‑concordant ST elevation in V1–V3 should be regarded as a STEMI‑equivalent pattern, strongly suggestive of proximal LAD‑culprit OMI and warranting immediate invasive evaluation and reperfusion. This case illustrates how the prompt recognition of this high-risk ECG presentation enabled timely PCI and how the Queen of Hearts AI application provided accurate, point-of-care confirmation of OMI and left ventricular dysfunction. Although AI‑based ECG tools appear promising adjuncts for real‑time ACS triage, they should complement rather than replace expert ECG interpretation and clinical judgment, and their broader performance must be validated beyond single‑case experience.

Authors: Lucio Giuseppe Granata, Francesco Russo, Simona Giubilato, Marilena Scarabelli, Francesco Amico

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

Can an AI ECG algorithm improve diagnostic accuracy for acute coronary occlusion in the difficult subset of canceled catheterization lab activations?

Discordance in ECG interpretation between Emergency Medicine and Cardiology teams is common, and within canceled STEMI activations, a true acute coronary occlusion myocardial infarction (OMI) can go unrecognized. This retrospective study examined whether an AI ECG algorithm (Queen of Hearts™) could improve OMI detection in this difficult subset. Across three referral centers, the investigators analyzed 185 activations canceled for not meeting STEMI criteria, of which 17 met the definition of a missed OMI. The AI algorithm identified 16 of 17 cases, far exceeding STEMI criteria in sensitivity (94.1% vs. 47.1%), supporting its use as an adjunct to clinical judgment in ambiguous cases.

Artificial Intelligence-Assisted, ECG-Based Triage of Patients With Chest Pain to Immediate Invasive Treatment

Rapid identification of acute coronary occlusion (ACO) is critical in chest pain patients, yet conventional STEMI criteria miss occlusion in many NSTEMI cases, delaying life-saving invasive treatment. This retrospective study tested whether a deep learning ECG AI model could improve ACO detection in an unselected cohort of more than 4,000 consecutive patients from a German chest pain unit. Each 12-lead ECG was assessed using both standard STEMI criteria and the AI model, with ACO independently adjudicated by a blinded physician. The AI model clearly outperformed STEMI criteria, identifying 73 of 104 ACO cases versus 30 (area under the curve 0.958 vs. 0.589), with fewer false positives. The findings suggest AI-assisted ECG interpretation can detect subtle ischemic changes beyond established criteria and support faster triage of NSTE-ACO patients to immediate invasive care.

Join over 100,000 healthcare professionals who are already taking advantage of AI